A minority of women of childbearing potential are tested for pregnancy before chemoimmunotherapy: An Australian Cancer Centre Experience.

Our results highlight a concerningly low rate of pregnancy screening in women of childbearing age receiving CIT. The implication of missing a positive pregnancy test in this group of women could result in foetal complication, accidental miscarriage, potential bleeding risks and avoidable psychosocial stress. This highlights the urgent need for guidelines to mandate pregnancy testing in women of childbearing age receiving CIT and evidence-based implementation tools. This article is protected by copyright. All rights reserved.